⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer

Official Title: A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors

Study ID: NCT04586270

Interventions

TAS0612

Study Description

Brief Summary: The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Tennessee Oncology, Nashville, Tennessee, United States

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Centre de Lutte Contre le Cancer Gustave Roussy, Villejuif, Val De Marne, France

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: